King Pharmaceuticals KG Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's change in other assets?
- King Pharmaceuticals (KG) reported change in other assets of -$139K in Q1 2026.
- How has King Pharmaceuticals's change in other assets changed year-over-year?
- King Pharmaceuticals's change in other assets decreased by 151.5% year-over-year, from $270K to -$139K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.